STS

pharmaceutical preparations; atenolol, a cardioselective adrenoreceptor blocking agent; famotidine, a histamine H2-receptor antagonist; piroxicam, a non-steroidal anti-inflammatory agent; nifedipine, a calcium channel blocker; and diltiazem, a calcium ion influx inhibitor